New group prepares for fight over drug compounders
By Paul C. Barton, Gannett Washington Bureau
WASHINGTON -- Battle lines on legislation to regulate drug compounders became clearer Tuesday as a new group lobbying on the issue announced its formation.
Called the Working Group on Pharmaceutical Safety, it will work to protect the interests of a handful of drug companies that want to prohibit compounders from making drugs similar to ones they make under Food and Drug Administration supervision.
The new group supports the bill coming out of the Senate Health Education Labor and Pensions Committee that would bring large-scale compounders under FDA regulation, particularly those that market products across state lines.
"It's incredibly necessary, particularly right now," said Sarah Sellers, a former FDA drug safety and compliance official helping lead the new group.
Republican Sen. Lamar Alexander of Tennessee, ranking minority member on the Senate committee, played a major role in drafting the legislation.
On the other side is the International Academy of Compounding Pharmacists, which sees the bill as failing to bring all compounders under the same rules, leaving exceptions for compounders such as those in hospital pharmacies.
"Safety regulations don't work when they don't apply to everybody," said David Ball, spokesman for IACP.
continue to read here
No comments:
Post a Comment